Poddar Richa 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Poddar Richa
Chief Commercial Officer
Transactions
- Tax Payment
Common stock
2022-02-14$30.50/sh−590$17,995→ 2,641 total - Exercise/Conversion
Common stock
2022-02-14+1,738→ 3,231 total - Exercise/Conversion
Restricted stock units
2022-02-14−1,738→ 1,738 total→ Common stock (1,738 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.